---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-082822"
form_type: "8-K"
ticker: "SRRK"
cik: "0001727196"
company_name: "Scholar Rock Holding Corp"
filed_at: "2022-07-26T23:59:59+00:00"
generated_at: "2026-06-24T08:48:59.780858+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Scholar Rock appoints Srinivas Akkaraju to Board of Directors

## Summary
- Board expanded to nine members; Dr. Akkaraju appointed as Class I director effective July 26, 2022.
- Akkaraju is founder and Managing General Partner at Samsara BioCapital, a recent investor in SRRK.
- He is deemed independent under NASDAQ rules and will receive standard non-employee director compensation.
- Akkaraju serves on boards of Chinook Therapeutics, Intercept Pharmaceuticals, Syros Pharmaceuticals, and others.

## SEC filing metadata
- accession: 0001104659-22-082822
- form_type: 8-K
- ticker: SRRK
- cik: 0001727196
- company_name: Scholar Rock Holding Corp
- filed_at: 2022-07-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1727196/000110465922082822/0001104659-22-082822-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1727196/000110465922082822/tm2221808d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-082822
- JSON: https://secwatch.observer/filing/0001104659-22-082822.json
- Plain text: https://secwatch.observer/filing/0001104659-22-082822.txt

## Key facts
- Executive change
  Srinivas Akkaraju was appointed as Director at Scholar Rock Holding Corp.
  - Action: appointed
  - Role: Director
  source text: increased the size of the Board to nine (9) directors and subsequently appointed Srinivas Akkaraju to join the Board filling the vacancy created by the increase in the size of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1727196/000110465922082822/0001104659-22-082822-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.